// App-Quantinova.ai

1736 : Mir Expression Profile of Peripheral Blood Lymphocytes Predicts Relapse in Pediatric Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Smadar Avigad

Principal Investigators

  • Keren Shichrur

  • Sara Elitzur

  • Gil Gilad

  • Shlomit Barzilai

  • Galia Avrahami

  • Nir Dotan

  • Jennifer Yarden

  • Isaac Yaniv

Medical Centers

  • Molecular Oncology, Felsenstein Medical Research Center, Sackler Faculty of Medicine Tel Aviv University, Petach Tikva, Israel

  • Research & Development, Curewize Health Ltd., Yokneam, Israel

  • Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah-Tikva, Israel

Locations

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • microRNA-1290

Drug/Treatment

  • Mofezolac

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved